Genetic insights into the morass of metastatic heterogeneity

KW Hunter, R Amin, S Deasy, NH Ha… - Nature Reviews …, 2018 - nature.com
Tumour heterogeneity poses a substantial problem for the clinical management of cancer.
Somatic evolution of the cancer genome results in genetically distinct subclones in the …

Combined Mutation of Apc, Kras, and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer

E Sakai, M Nakayama, H Oshima, Y Kouyama, A Niida… - Cancer research, 2018 - AACR
Colorectal cancer is driven by the accumulation of driver mutations, but the contributions of
specific mutations to different steps in malignant progression are not fully understood. In this …

The RAS mutation status predicts survival in patients undergoing hepatic resection for colorectal liver metastases: The results from a genetic analysis of all‐RAS

K Amikura, K Akagi, T Ogura… - Journal of surgical …, 2018 - Wiley Online Library
Introduction We investigated the impact of mutations in KRAS exons 3‐4 and NRAS exons 2‐
3 in addition to KRAS exon 2, so‐called all‐RAS mutations, in patients with colorectal liver …

Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?

G Passot, BJ Kim, O Glehen, RJ Mehran… - Annals of surgical …, 2018 - Springer
Background RAS mutation status is an important prognostic factor after resection of liver
metastases (LiM) from colorectal cancer (CRC). The prognostic significance of RAS after …

[HTML][HTML] Mutational profile of colorectal cancer lung metastases and paired primary tumors by targeted next generation sequencing: implications on clinical outcome …

T Schweiger, S Liebmann-Reindl… - Journal of Thoracic …, 2018 - ncbi.nlm.nih.gov
Background Pulmonary metastasectomy is one of the cornerstones in the treatment of
oligometastatic colorectal cancer (CRC). However, the selection of patients who benefit from …

Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer

TD Christensen, JA Palshof, FO Larsen… - Acta …, 2018 - Taylor & Francis
Background: Several studies have investigated correlations between metastatic pattern and
mutation status in patients with colorectal cancer (CRC). However, most of the studies were …

[HTML][HTML] Inducible intestine-specific expression of krasV12 triggers intestinal tumorigenesis in transgenic zebrafish

JW Lu, D Raghuram, PSA Fong, Z Gong - Neoplasia, 2018 - Elsevier
KRAS mutations are a major risk factor in colorectal cancers. In particular, a point mutation of
KRAS of amino acid 12, such as KRAS V12, renders it stable activity in oncogenesis. We …

[HTML][HTML] Hotspot KRAS exon 2 mutations in CD166 positive colorectal cancer and colorectal adenoma cells

HL Wong, LPW Ng, SP Koh, LWC Chan, EYK Wong… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the third most common cancer and the fourth leading cause of
cancer deaths worldwide. Recent studies have shown that cancer stem cells (CSCs) are an …

[PDF][PDF] Combined mutation of Apc, Kras and Tgfbr2 effectively drives metastasis of intestinal cancer

坂井絵梨 - 2018 - kanazawa-u.repo.nii.ac.jp
Colorectal cancer is driven by the accumulation of driver mutations, but the contributions of
specific mutations to different steps in malignant progression are not fully understood. In this …